-+ 0.00%
-+ 0.00%
-+ 0.00%

InflaRx appoints Gabriela Alperovich as SVP, global head of clinical development

PUBT·10/01/2026 11:31:43
Listen to the news
InflaRx appoints Gabriela Alperovich as SVP, global head of clinical development
  • InflaRx appointed Gabriela Alperovich as senior vice president and global head of clinical development, effective Oct. 1, 2026.
  • Alperovich most recently served at CSL Vifor as executive director and global clinical lead for cardiovascular and renal programs.
  • Her prior roles include clinical development or medical affairs leadership at CSL Vifor, AbbVie, and Bristol-Myers Squibb.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inflarx NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010730PRIMZONEFULLFEED9837813) on October 01, 2026, and is solely responsible for the information contained therein.